LaBaer Heads to Arizona State for New Biomarker Initiative | GenomeWeb

In an effort to add to Arizona's personalized medicine initiative, the Biodesign Institute at Arizona State University and the Virginia G. Piper Charitable Trust have hired Harvard's Joshua LaBaer to head the new Virginia G. Piper Center for Personalized Diagnostics. LaBaer will collaborate with teams from the larger Partnership for Personalized Medicine, which includes TGen in Phoenix and the Fred Hutchinson Cancer Research Center in Seattle.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.